to Develop Platelet-Stimulating Proteins For Treating Thrombocytopenia >>Click here for complete News Release 10-9-2003 Wheat Ridge, Colorado Bolder BioTechnology Receives U.S... Institute to Develop Therapeutic Proteins for Treating Thrombocytopenia >>Click here for complete News Release Back to News About Us - Technology - Products - People - News - Careers...

Click here for complete... Bolder BioTechnology Receives Phase II SBIR Grant to Develop Long-Acting Cytokine Conjugates for Treating Thrombocytopenia Wheat Ridge, Colorado... generation forms of interleukin-11 (IL-11) for the treatment of chemotherapy-induced thrombocytopenia. Receipt of the entire grant award is contingent upon the achievement of certain...

II SBIR Grant to Develop Long-Acting Cytokine Conjugates for Treating Thrombocytopenia >>Click here for complete News Release Back to News About Us - Technology - Products...

., Company President stated IL-11 is a multifunctional protein that is used clinically to treat thrombocytopenia (low platelet counts) in cancer patients receiving chemotherapy. Dr...

Interferon Site-specific PEGylation Immunodeficiencies BBT-030 IL-11 Site-specific PEGylation Thrombocytopenia BBT-031, a long-acting Growth Hormone product Growth Hormone stimulates... to reverse thrombocytopenia (low platelet counts), which is a frequent side-effect of chemotherapy treatment in cancer patients. Our site-specific PEGylated IL-11 analog, BBT-045...